Apollo Global Management
all pathways of capital deployment drive earnings accretion | Apollo Global Management
Company
Deck Type
Sector
Industry
Deck date
June 2022
Slide
134 of 157
Related slides by other companies
AstraZeneca
Results
November 2023
capital allocation capital allocation strategy unchanged investments to drive future growth reinvestment in the business free post currently projects in phase development investments behind launches in new indications and strengthening leadership in existing therapy areas continued investments in new technologies and platforms including cell and gene therapies progressive dividend policy value accretive deals continue to leverage partnerships to drive innovation and bring medicines to markets priority remains in our business new approvals in major markets | AstraZeneca
AstraZeneca
Investor Conference
January 2023
capital allocation priorities global spend | AstraZeneca
Benson Hill
Results
March 2024
transformation of hill announced transition announced exploration of strategic alternatives framed new business model built new business model reshaped organization announced transition expanded liquidity improvement plan developed capital model finalized capital model divested facility and idle tech asset technology pipeline initiated partnership discussions with seed cos advanced partnership discussions with seed cos secured partner for animal feed study divested facility retired debt launched animal feed study a | Benson Hill
Melrose
Investor Presentation
May 2023
strategy and capital allocation | Melrose
Other recent decks by Apollo Global Management
See all presentations (29 decks)
Results
November 2024
Results
February 2024
Investor Day
November 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights